Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review
Background:
Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation. We conducted a systematic review of pre-ART retention in care in Africa.
Methods and Findings:
We searched PubMed, ISI Web of Knowledge, conference abstracts, and reference lists for reports on the proportion of adult patients retained between any two points between testing positive for HIV and initiating ART in sub-Saharan African HIV/AIDS care programs. Results were categorized as Stage 1 (from HIV testing to receipt of CD4 count results or clinical staging), Stage 2 (from staging to ART eligibility), or Stage 3 (from ART eligibility to ART initiation). Medians (ranges) were reported for the proportions of patients retained in each stage. We identified 28 eligible studies. The median proportion retained in Stage 1 was 59% (35%–88%); Stage 2, 46% (31%–95%); and Stage 3, 68% (14%–84%). Most studies reported on only one stage; none followed a cohort of patients through all three stages. Enrollment criteria, terminology, end points, follow-up, and outcomes varied widely and were often poorly defined, making aggregation of results difficult. Synthesis of findings from multiple studies suggests that fewer than one-third of patients testing positive for HIV and not yet eligible for ART when diagnosed are retained continuously in care, though this estimate should be regarded with caution because of review limitations.
Conclusions:
Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility. Better health information systems that allow patients to be tracked between service delivery points are needed to properly evaluate pre-ART loss to care, and researchers should attempt to standardize the terminology, definitions, and time periods reported.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. PLoS Med 8(7): e32767. doi:10.1371/journal.pmed.1001056
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001056
Souhrn
Background:
Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation. We conducted a systematic review of pre-ART retention in care in Africa.
Methods and Findings:
We searched PubMed, ISI Web of Knowledge, conference abstracts, and reference lists for reports on the proportion of adult patients retained between any two points between testing positive for HIV and initiating ART in sub-Saharan African HIV/AIDS care programs. Results were categorized as Stage 1 (from HIV testing to receipt of CD4 count results or clinical staging), Stage 2 (from staging to ART eligibility), or Stage 3 (from ART eligibility to ART initiation). Medians (ranges) were reported for the proportions of patients retained in each stage. We identified 28 eligible studies. The median proportion retained in Stage 1 was 59% (35%–88%); Stage 2, 46% (31%–95%); and Stage 3, 68% (14%–84%). Most studies reported on only one stage; none followed a cohort of patients through all three stages. Enrollment criteria, terminology, end points, follow-up, and outcomes varied widely and were often poorly defined, making aggregation of results difficult. Synthesis of findings from multiple studies suggests that fewer than one-third of patients testing positive for HIV and not yet eligible for ART when diagnosed are retained continuously in care, though this estimate should be regarded with caution because of review limitations.
Conclusions:
Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility. Better health information systems that allow patients to be tracked between service delivery points are needed to properly evaluate pre-ART loss to care, and researchers should attempt to standardize the terminology, definitions, and time periods reported.
: Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund 2010 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; progress report 2010 Geneva World Health Organization Available: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf. Accessed 13 June 2011
2. FoxMPRosenS 2010 Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 15 Suppl 1 1 15
3. BrinkhofMWDabisFMyerLBangsbergDRBoulleA 2008 Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86 559 567
4. LeisegangRClearySHislopMDavidseARegensbergL 2009 Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med 6 e1000189 doi:10.1371/journal.pmed.1000189
5. AlcornK 2010 March 25 South Africa to launch mass HIV testing drive in April, to test 15 million in one year. AIDSMap News, NAM Publications. Available: http://www.aidsmap.com/South-Africa-to-launch-mass-HIV-testing-drive-in-April-to-test-15-million-in-one-year/page/1438260/. Accessed 13 June 2011
6. CornellMGrimsrudAFairallLFoxMPvan CutsemG 2010 Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS 24 2263 2270
7. KeiserOAnastosKSchechterMBalestreEMyerL 2008 Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 13 870 879
8. GengEHNashDKambuguAZhangYBraitsteinP 2010 Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7 234 244
9. JaniISitoeNAlfaiEChongoPLeheJ 2010 Point-of-care CD4 improves patient retention and time-to-initiation of ART in Mozambique [abstract]. Abstract FRLBE101. XVIII International AIDS Conference; 18–23 July 2010; Vienna, Austria
10. FaalMNaidooNMakgamathaLVenterFOsihR 2010 Effect of an immediate CD4 result during VCT on patient retention in ART [abstract]. Abstract TUPE0113. XVIII International AIDS Conference; 18–23 July 2010; Vienna, Austria
11. Mtapuri-ZinyoweraSChidemeMMangwanyaDMugurungiOGudukeyaS 2010 Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 55 1 7
12. LarsonBANdibongoBBrennanABistlineKXuluT 2011 Point-of-care CD4 testing after HIV diagnosis to reduce losses to initiation of antiretroviral therapy: an evaluation of a pilot program at the Themba Lethu Clinic, Johannesburg, South Africa [abstract]. South African AIDS Conference; 7–10 June 2011; Durban, South Africa
13. LarsonBABistlineKNdibongoBXuluTBrennanA 2011 Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa [abstract]. South African AIDS Conference; 7–10 June 2011; Durban, South Africa
14. KohlerPChungMBenki-NugentSMcGrathCAttwaM 2011 Free CTX substantially improves retention among ART-ineligible clients in a Kenyan HIV treatment program [abstract]. Abstract 1018. 18th Conference on Retroviruses and Opportunistic Infections; 28 February–3 March 2011; Boston, Massachusetts, United States of America
15. FraserHSAllenCBaileyCDouglasGShinS 2007 Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J Med Internet Res 9 e29
16. AssefaYVanDMariamDHKloosH 2010 Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS 24 521 525
17. BerhanuAL 2009 Confirmed referral for pre-ART and ART services: best practices from USAID/PSP-Ethiopia mobile HIV counseling and testing [abstract]. Abstract 1462. HIV Implementers Conference; 10–14 June 2009; Windhoek, Namibia
18. MulissaZJereneDLindtjørnB 2010 Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS ONE 5 e13268 doi:10.1371/journal.pone.0013268
19. KarcherHOmondiAOderaJKunzAHarmsG 2007 Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12 687 694
20. AmollohMMedleyAOwuorPAudiBSeweM 2011 Factors associated with early uptake of HIV care and treatment services after testing HIV+ during home-based testing and counseling in rural Western Kenya [abstract]. Abstract 1077. 18th Conference on Retroviruses and Opportunistic Infections; 28 February–3 March 2011; Boston, Massachusetts, United States of America
21. GaretaDTweyaHWeigelRPhiriSChiwokoJ 2010 Linking HIV-infected pregnant women to antiretroviral therapy: experience from Lilongwe, Malawi [abstract]. Abstract MOPE0277. XVIII International AIDS Conference; 18–23 July 2010; Vienna, Austria
22. Tayler-SmithKZachariahRMassaquoiMManziMPasulaniO 2010 Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg 104 313 319
23. ZachariahRHarriesADManziMGomaniPTeckR 2006 Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS ONE 1 e121 doi:10.1371/journal.pone.0000121
24. MicekMGimbel-SherrKBaptistaAJMatedianaEMontoyaP 2009 Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr 52 397 405
25. AprilMDWalenskyRPChangYPittJFreedbergKA 2009 Testing rates and outcomes in a South African community, 2001–2006: implications for expanded screening policies. J Acquir Immune Defic Syndr 51 2001 2006
26. BassettIVWangBChettySMazibukoMBearnotB 2009 Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51 135 139
27. BassettIVReganSChettySGiddyJUhlerLM 2010 Who starts antiretroviral therapy in Durban, South Africa?…not everyone who should. AIDS 24 Suppl 1 S37 S44
28. IngleSMMayMUebelKTimmermanVKotzeE 2010 Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS 24 2717 2725
29. KaplanROrrellCZwaneEBekkerLGWoodR 2008 Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22 1679 1681
30. KranzerKZeineckerJGinsbergPOrrellCKalaweNN 2010 Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE 5 e13801 doi:10.1371/journal.pone.0013801
31. LarsonBABrennanAMcNamaraLLongLRosenS 2010 Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ 88 675 680
32. LarsonBABrennanAMcNamaraLLongLRosenS 2010 Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 Suppl 1 43 47
33. LawnSDMyerLHarlingGOrrellCBekkerLG 2006 Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43 770 776
34. LessellsRJMutevedziPCCookeGSNewellML 2011 Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 56 e79 e86
35. LosinaEBassettIVGiddyJChettySReganS 2010 The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS ONE 5 8 doi:10.1371/journal.pone.0009538
36. LusenoWWechsbergWMiddlesteadt-EllersonRGumulaW 2008 Linkages and barriers to care for high-risk South African women testing positive for HIV [abstract]. Abstract TUPE0209. XVII International AIDS Conference; 3–8 August 2008; Mexico City, Mexico
37. NaidooNPFaalMVenterWDFOsihR 2010 Patient retention-reasons why patients do or do not come back for care after HIV testing [abstract]. Abstract THPE0798. XVIII International AIDS Conference; 18–23 July 2010; Vienna, Austria
38. GovindasamyDvan SchaikNKranzerKMpaliMThuebusE 2011 Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata [abstract]. Abstract 1076. 18th Conference on Retroviruses and Opportunistic Infections; 28 February–3 March 2011; Boston, Massachusetts, United States of America
39. NsigayeRWringeARouraMKalluvyaSUrassaM 2009 From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc 12 31
40. AmuronBNamaraGBirungiJNabiryoCLevinJ 2009 Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9 290
41. WanyenzeRKHahnJLiechtyCRaglandKRonaldA 2011 Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav 15 751 760
42. GengEMuyindikeWGliddenDBwanaMYiannoutsosCT 2011 Failure to initiate ART, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda: Understanding engagement in care in resource-limited settings [abstract]. Abstract 1017. 18th Conference on Retroviruses and Opportunistic Infections; 28 February–3 March 2011; Boston, Massachusetts, United States of America
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Individualized Cost-Effectiveness Analysis
- GeneXpert—A Game-Changer for Tuberculosis Control?
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
- Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort